medications
To investigate its effects in       a clinical practice setting, we evaluated zafirlukast in a heterogeneous group of       patients who had asthma of different degrees of severity and who were receiving       concomitant asthma medications.
To investigate its effects in       a clinical practice setting, we evaluated zafirlukast in a heterogeneous group of        @OBJECT$  who had asthma of different degrees of severity and who were  @PREDICAT$        concomitant asthma  @SUBJECT$ .